China Bans Shenzhen Hepatitis B Vaccine following 4 Infant Deaths
Xinhua Web Editor: Liu Yuanhui
Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company.
The circular, jointly issued by the China Food and Drug Administration (CFDA) and the National Health and Family Planning Commission (NHFPC), said that four cases of infants' deaths were reported in Hunan, Guangdong and Sichuan provinces after inoculation using the vaccine.
The CFDA and the NHFPC will carry out further investigation into the cases and inspection over the company , the circular said.
CRIENGLISH.com claims the copyright of all material and information produced
originally by our staff. All rights reserved. Reproduction of text for non-commercial
purposes only is permitted provided that both the source and author are
acknowledged and a notifying email
is sent to us.
CRIENGLISH.com holds neither liability nor responsibility for materials
attributed to any other source. Such information is provided as reportage
and dissemination of information but does not necessarily reflect the opinion
of or endorsement by CRI.